Suchergebnisse - "Thomson, Rachel"

PubPharm (14)

1

In vitro susceptibility testing of imipenem-relebactam and tedizolid against 102 Mycobacterium abscessus isolates

enthalten in: International journal of antimicrobial agents | 2023

von Burke, A. | Carter, R. | Tolson, C. | +6

2

A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis

enthalten in: BMC pulmonary medicine | 2023

von Ryan, H. | Ballard, E. | Stockwell, R. | +4

3

Carriage and Transmission of Macrolide Resistance Genes in Patients With Chronic Respiratory Conditions and Their Close Contacts

enthalten in: Chest | 2022

von Wang, Y. | Taylor, S. | Choo, J. | +7

4

Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease : Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure

enthalten in: Chest | 2021

von Griffith, D. | Thomson, R. | Flume, P. | +14

5

Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis

enthalten in: Clinical pharmacokinetics | 2021

von Burke, A. | Smith, D. | Coulter, C. | +3

6

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease : A 12-Month Open-Label Extension Clinical Trial

enthalten in: Annals of the American Thoracic Society | 2021

von Winthrop, K. | Flume, P. | Thomson, R. | +13

7

Management of Australian Adults with Bronchiectasis in Tertiary Care : Evidence-Based or Access-Driven?

enthalten in: Lung | 2019

von Visser, S. | Bye, P. | Fox, G. | +11

8

The clinical significance of Mycobacterium triplex

enthalten in: Respiratory medicine | 2019

von Gibson, J. | Baird, T. | Pandey, S. | +4

9

M ycobacterium abscessus pulmonary disease : individual patient data meta-analysis

enthalten in: The European respiratory journal | 2019

von Kwak, N. | Dalcolmo, M. | Daley, C. | +11

CommentIn: Eur Respir J. 2019 Jul 11;54(1):. - PMID 31296783

10

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study

enthalten in: American journal of respiratory and critical care medicine | 2018

von Griffith, D. | Eagle, G. | Thomson, R. | +122

CommentIn: Am J Respir Crit Care Med. 2018 Dec 15;198(12):1473-1475. - PMID 30365392